FI913835A - 6-substituerade-tetrahydrobenz(cd) indoler. - Google Patents

6-substituerade-tetrahydrobenz(cd) indoler. Download PDF

Info

Publication number
FI913835A
FI913835A FI913835A FI913835A FI913835A FI 913835 A FI913835 A FI 913835A FI 913835 A FI913835 A FI 913835A FI 913835 A FI913835 A FI 913835A FI 913835 A FI913835 A FI 913835A
Authority
FI
Finland
Prior art keywords
tetrahydrobenz
indoler
substituerade
indoles
benefited
Prior art date
Application number
FI913835A
Other languages
English (en)
Other versions
FI913835A0 (fi
FI102677B (fi
FI102677B1 (fi
Inventor
Michael Edward Flaugh
Michael John Martinelli
John Mehnert Schaus
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI913835A0 publication Critical patent/FI913835A0/fi
Publication of FI913835A publication Critical patent/FI913835A/fi
Application granted granted Critical
Publication of FI102677B publication Critical patent/FI102677B/fi
Publication of FI102677B1 publication Critical patent/FI102677B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI913835A 1990-08-15 1991-08-13 Menetelmä terapeuttisesti käyttökelpoisten 6-asyylisubstituoitujen 4-aminotetrahydrobentso[cd]indolien valmistamiseksi FI102677B1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56799090A 1990-08-15 1990-08-15
US07/725,175 US5229409A (en) 1990-08-15 1991-07-03 6-substituted-tetrahydrobenz[cd]indoles

Publications (4)

Publication Number Publication Date
FI913835A0 FI913835A0 (fi) 1991-08-13
FI913835A true FI913835A (fi) 1992-02-16
FI102677B FI102677B (fi) 1999-01-29
FI102677B1 FI102677B1 (fi) 1999-01-29

Family

ID=27074632

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913835A FI102677B1 (fi) 1990-08-15 1991-08-13 Menetelmä terapeuttisesti käyttökelpoisten 6-asyylisubstituoitujen 4-aminotetrahydrobentso[cd]indolien valmistamiseksi

Country Status (25)

Country Link
US (1) US5229409A (fi)
EP (1) EP0471576B1 (fi)
JP (1) JP3034085B2 (fi)
KR (1) KR100221159B1 (fi)
CN (1) CN1031999C (fi)
AT (1) ATE234285T1 (fi)
AU (1) AU648575B2 (fi)
BR (1) BR9103481A (fi)
CA (1) CA2049212C (fi)
CZ (1) CZ280605B6 (fi)
DE (1) DE69133212T2 (fi)
DK (1) DK0471576T3 (fi)
ES (1) ES2194007T3 (fi)
FI (1) FI102677B1 (fi)
HU (1) HU220757B1 (fi)
IE (1) IE912878A1 (fi)
IL (1) IL99148A (fi)
MX (1) MX9100646A (fi)
MY (1) MY106764A (fi)
NO (1) NO176020C (fi)
NZ (1) NZ239333A (fi)
PT (1) PT98640B (fi)
RU (1) RU2073672C1 (fi)
TW (1) TW197422B (fi)
YU (1) YU48058B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
TW219933B (fi) * 1990-02-26 1994-02-01 Lilly Co Eli
US5340838A (en) * 1990-05-04 1994-08-23 Eli Lilly And Company Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines
US5089517A (en) * 1990-08-03 1992-02-18 The Board Of Trustees Of The Leland Stanford Junior University Neuroprotection by indolactam v and derivatives thereof
US5229410A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
NZ260667A (en) * 1993-06-10 1997-05-26 Lilly Co Eli Preventing emesis or treating sexual dysfunction using tetrahydrobenz[cd]indole 6-carboxamides
US5385928A (en) * 1994-05-18 1995-01-31 Eli Lilly And Company Tetrahydrobenz [CD] indazoles, compositions and use

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE517732C (de) * 1927-10-27 1931-02-09 Then Rudolf Faerbekufe mit einem drehbaren, trommelartigen Rahmen fuer die auf aus-wechselbaren Faerbestoecken aufgehaengten Waren, insbesondere Struempfe
US3194811A (en) * 1963-09-05 1965-07-13 Merck & Co Inc Aroyl-benzindolyl acids
BE755270A (fr) * 1969-08-27 1971-02-25 Sandoz Sa Nouveaux derives du benzo(cd)indole, leur preparation et medicaments contenant ces derives
BE757879A (fr) * 1969-10-24 1971-04-22 Sandoz Sa Derives du benzo(cd)indole, leur preparation et medicaments contenant ces derives
FI206974A (fi) * 1973-07-16 1975-01-17 Sandoz Ag
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
US4282240A (en) * 1979-11-23 1981-08-04 Merck & Co., Inc. Amino substituted tetrahydrobenzindoles
FR2510111A1 (fr) * 1981-07-24 1983-01-28 Roussel Uclaf Nouveaux derives du piperidin-3-yl indole, leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
FR2522658A1 (fr) * 1982-03-05 1983-09-09 Roussel Uclaf Application a titre de medicaments de derives du trans 4-amino benz (c,d) indol-5-ol ainsi que de leurs sels, compositions les renfermant, nouveaux derives et leur procede de preparation
DE3346573A1 (de) * 1983-12-23 1985-07-04 Troponwerke GmbH & Co KG, 5000 Köln 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
US4983622A (en) * 1984-02-06 1991-01-08 Eli Lilly And Company 6-substituted-4-dialkylaminotetrahydrobenz(c,d)indoles
IL74222A (en) * 1984-02-06 1988-07-31 Lilly Co Eli 6-substituted-4-dialkylamino tetrahydrobenz(c,d)indoles,their preparation and pharmaceutical compositions comprising them
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
CA1266482A1 (en) * 1984-05-24 1990-03-06 Carl Kaiser 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines
DE3525564A1 (de) * 1985-07-15 1987-02-05 Schering Ag Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
JPH07103105B2 (ja) * 1989-05-12 1995-11-08 杏林製薬株式会社 インドール誘導体及びその製造方法
US5039820A (en) * 1990-02-26 1991-08-13 Eli Lilly And Company 4-amino-6-iodo-hexahydrobenz(cd)indoles
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion

Also Published As

Publication number Publication date
CZ280605B6 (cs) 1996-03-13
FI913835A0 (fi) 1991-08-13
US5229409A (en) 1993-07-20
AU648575B2 (en) 1994-04-28
NO913159D0 (no) 1991-08-13
CS249491A3 (en) 1992-03-18
CA2049212C (en) 2003-04-08
HU220757B1 (hu) 2002-05-28
KR920004347A (ko) 1992-03-27
JPH04230663A (ja) 1992-08-19
FI102677B (fi) 1999-01-29
KR100221159B1 (ko) 1999-09-15
DE69133212T2 (de) 2003-11-20
NO913159L (no) 1992-02-17
RU2073672C1 (ru) 1997-02-20
DK0471576T3 (da) 2003-12-01
EP0471576A1 (en) 1992-02-19
EP0471576B1 (en) 2003-03-12
CA2049212A1 (en) 1992-02-16
IE912878A1 (en) 1992-02-26
AU8240691A (en) 1992-02-27
BR9103481A (pt) 1992-05-12
IL99148A (en) 1995-12-08
HUT59094A (en) 1992-04-28
ES2194007T3 (es) 2003-11-16
DE69133212D1 (de) 2003-04-17
YU140491A (sh) 1994-01-20
NZ239333A (en) 1993-05-26
JP3034085B2 (ja) 2000-04-17
TW197422B (fi) 1993-01-01
ATE234285T1 (de) 2003-03-15
MX9100646A (es) 1992-04-01
MY106764A (en) 1995-07-31
CN1058961A (zh) 1992-02-26
PT98640B (pt) 1999-01-29
YU48058B (sh) 1996-10-18
CN1031999C (zh) 1996-06-12
FI102677B1 (fi) 1999-01-29
PT98640A (pt) 1992-06-30
HU912706D0 (en) 1992-01-28
NO176020C (no) 1995-01-18
NO176020B (no) 1994-10-10

Similar Documents

Publication Publication Date Title
DK0506363T3 (da) 6-heterocyklisk-4-amino-1,3,4,5-tetrahydrobenz[cd]indoler
FI913835A (fi) 6-substituerade-tetrahydrobenz(cd) indoler.
FI921346A (fi) 6-heterocyklisk-4-amino-1,2,2a,3,4,5-hexahydrobens/cd/indoler
EP0444854A3 (en) 6-substituted-hexahydrobenz(cd)indoles
DK0434202T3 (da) Azabicycloamider og -estere som 5-HT3-receptor-antagonister

Legal Events

Date Code Title Description
FG Patent granted

Owner name: ELI LILLY AND COMPANY

MA Patent expired